EUVIMEDEUVIMED entdecken
Leserbrief

Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study

Shaoxiang Huang, Xueyu Wang, Peili Zhang

European Journal of Cancer · 2025-11 · 230 · 116032

DOI: 10.1016/j.ejca.2025.116032 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Cancer, 2025-11. Verfasst von Shaoxiang Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shanxi Medical University, 030000, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • School of Nursing, Shanxi Medical University, 030000, China.
  • School of Nursing, Shanxi Medical University, 030000, China. Electronic address: work7work7@163.com.

Zitieren

APA

Huang, S., Wang, X., & Zhang, P. (2025). Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. European Journal of Cancer, 230, 116032. https://doi.org/10.1016/j.ejca.2025.116032

Vancouver

Huang S, Wang X, Zhang P. Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study. European Journal of Cancer. 2025;230:116032. doi:10.1016/j.ejca.2025.116032

BibTeX
@article{Huang2025,
  author = {Huang, Shaoxiang and Wang, Xueyu and Zhang, Peili},
  title = {Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {230},
  pages = {116032},
  doi = {10.1016/j.ejca.2025.116032}
}
Kostenlos starten →